Biontech Europe GmbH
Pharmaceutical Companies · Mainz
Biontech Europe GmbH is a pharmaceutical company based in Mainz, Germany.
Content in German
The detailed company information on this page is provided in the original German language. You can use your browser's built-in translation feature to view it in English.
Right-click on the page and select "Translate to English" or use the translation icon in your browser's address bar.
Biontech Europe GmbH – Address & Contact
Biontech Europe GmbH Overview
Biontech Europe GmbH is a pharmaceutical company based in Mainz, Rheinland-Pfalz. The company operates in the German pharmaceutical market and is regulated by the BfArM (Federal Institute for Drugs and Medical Devices).
Activities & Products
Pharmaceutical companies such as Biontech Europe GmbH develop, produce or distribute medicines for the German and international market. All authorised products are subject to approval and are regulated by BfArM or the European Medicines Agency (EMA).
About Biontech Europe GmbH
Mit unserer Grandlagenforschung and the development of Immuntherapien and mRNA-Impfstoffen möchten wir the Gesandheit of Menschen weltweit verbessern. Unser Glaube of wissenschaftliche Präzision, Innovation and Leidenschaft treibt uns thereby of. BioNTech wurde of sciencelern and sciencelerinnen, Ärztinnen and Ärzten gegründet, um durch the Kombination of science and theen […]
Location & Contact
Biontech Europe GmbH can be reached at the following address: An Der Goldgrube 12, 55131 Mainz – Phone: 0613190840. For current information and enquiries, please contact the company directly.
More information: Pharmaunternehmen in Rheinland-Pfalz or all Pharmaunternehmen in Germany on Sanoliste.
Frequently asked questions about Biontech Europe GmbH
What does BioNTech Europe GmbH do?
BioNTech is ein deutsches Biotech-company aus Mainz, bekannt als Entwickler des ersten mRNA-COVID-19-Impfstoffs. The company forscht an mRNA-Immuntherapien gegen Krebs and Infektionskrankheiten.
Was ist mRNA-Technologie bei BioNTech?
mRNA-Technologie verwendet genetische Anweisungen (mRNA), um the Immunsystem zu trainieren, bestimmte Krankheiten zu bekämpfen. BioNTech hat these Technologie zur Marktreife gebracht and nutzt sie for Impfstoffe and Krebstherapien.
Forscht BioNTech an Krebstherapien?
Ja, BioNTech hat about 25 klinische Phase-2- and Phase-3-Stuthen im Bereich Krebsimmuntherapie lonen. The company develops individualisierte mRNA-basierte Krebstherapien, the on the Profil jedes patients zugeschnitten are.
More Pharmaceutical Companies in Mainz
Pharmaceutical Companies in Germany
Related areas in healthcare
Pharmaceutical Companies in Rheinland-Pfalz
All Pharmaceutical Companies in Rheinland-Pfalz on Sanoliste — or discover all categories by federal state.